Zobrazeno 1 - 10
of 59
pro vyhledávání: '"M. Keisu"'
Publikováno v:
European Journal of Haematology. 45:11-14
There were 100 patients with pancytopenia notified to the Swedish part of an international study of aplastic anemia (Aa) (1983–1986). Aa was the cause in 16 patients and 50 patients had different conditions explaining their pancytopenia, whereas in
Publikováno v:
European Journal of Clinical Pharmacology. 43:215-218
During the 18 year period 1972-1989 a total of 62 cases of agranulocytosis associated with the use of sulphasalazine were reported to the Swedish Adverse Drug Reactions Advisory Committee (SADRAC). The median age of the patients was 52 y and median d
Autor:
M, Keisu, T B, Andersson
Publikováno v:
Handbook of experimental pharmacology. (196)
Ximelagatran was the first orally available direct thrombin inhibitor under clinical development that also reached the market. Ximelagatran was tested in an extensive clinical programme. Short-term use (12 days) in humans including the phase III clin
Autor:
M. Keisu, Tommy B. Andersson
Publikováno v:
Handbook of Experimental Pharmacology ISBN: 9783642006623
Ximelagatran was the first orally available direct thrombin inhibitor under clinical development that also reached the market. Ximelagatran was tested in an extensive clinical programme. Short-term use ( 35 days) use of ximelagatran (incidence of >3x
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2de92af51a830a2e40bb932407c01bf
https://doi.org/10.1007/978-3-642-00663-0_13
https://doi.org/10.1007/978-3-642-00663-0_13
Publikováno v:
International journal of clinical pharmacology and therapeutics. 46(7)
Aims: Causality assessment in drug-induced liver injury is often based on circumstantial evidence rather than a formal, systematic review. The Roussel Uclaf Causality Assessment Method (RUCAM) provides a more objective means of assessing causality of
Publikováno v:
Journal of Internal Medicine. 228:353-360
During the 10-year period 1976-1985, a total of 154 cases of blood dyscrasia were reported in Sweden which were evaluated as having a probable or possible causal relationship with trimethoprim-sulphamethoxazole (T-SM). There were 61 cases of leucopen
Publikováno v:
European journal of clinical pharmacology. 55(9)
To study the influence of food intake on electrocardiogram (ECG) variables (heart rate, QT-, QTc-, PR-intervals, QRS-time) and morphological alterations of the T-waves in 12 healthy male volunteers.The study was of open, three-period crossover design
Publikováno v:
Lakartidningen. 94(30-31)
Publikováno v:
European journal of clinical pharmacology. 43(3)
A comparison has been made of risk estimates for agranulocytosis connected with sulphasalazine and trimethoprim-sulphamethoxazole (T-SM) therapy calculated from data in the Swedish Drug Monitoring System (“spontaneous” reports, sales and prescrip
Publikováno v:
Blut. 61(4)
From a population-based study on the incidence of potentially drug-associated blood dyscrasias 28 cases were identified with pancytopenia. Who recovered within 90 days after diagnosis. Early recovery occurred more frequently in patients showing norma